(1)
Edina, B. C.; Rinaldi, I. Effectiveness of Bendamustine-Rituximab Compared to R-CHOP/R-CVP As a First-Line Treatment of Indolent Non-Hodgkin’s Lymphoma or Mantle-Cell Lymphoma. Acta Med Indones 2022, 54, 316.